Celltrics expands pet diagnostics service ahead of Kosdaq listing

Celltrics, a food and animal safety diagnostics company, said Friday it has upgraded the test-request system for its companion animal diagnostic service Korea Vet Lab (KVL) and launched full commercial operations this month.

KVL analyzes pet samples submitted by veterinary clinics and delivers test results back to those clinics. More than 2,000 veterinary clinics across the country currently use the service. Through the system overhaul, Celltrics plans to strengthen AI-based features and improve the overall user experience from test submission through results delivery. The company aims to boost satisfaction among existing customers while also attracting new veterinary clinic clients.

Sales from Celltrics' companion animal diagnostics business have grown consistently. Revenue from the segment rose from 3.4 billion won ($2.52 million) in 2023 to 4.3 billion won in 2024 and 5.1 billion won last year. The segment accounted for 29.9 percent of the company's total sales of 17 billion won last year, and contributed 3.1 billion won — 29.6 percent — of total sales of 10.4 billion won in the first half of this year. Celltrics projects the companion animal diagnostics segment will reach 7 billion won in sales this year.

Celltrics plans to expand its service scope beyond disease diagnosis into preventive health screening. The company intends to add more health checkup categories and introduce an AI-based service that recommends additional screening items to veterinary clinics based on test results. The initiative is designed to meet growing demand for early-detection health screenings for companion animals.

"The role of a diagnostic testing service extends from ensuring the test-request process does not interrupt the clinical workflow all the way to making sure results are properly communicated to pet owners," a Celltrics official said. "KVL is not an electronic medical records provider, so we do not hold all of an animal's clinical information — but as a diagnostic center, we will keep finding ways to expand our service scope based on the testing data we do have."

Celltrics is pursuing a Kosdaq listing through a merger with IBKS No. 25 Special Purpose Acquisition. The Korea Exchange granted preliminary approval for the Kosdaq listing on Sept. 28. Founded in 2019, Celltrics develops diagnostic products and testing services for the food safety, livestock and companion animal sectors, drawing on antigen-antibody-based immunodiagnostics and molecular diagnostics technology.